

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.73986838 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 5.04015132 |
| 3 | proteasome assembly (GO:0043248) | 4.84198619 |
| 4 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.48942818 |
| 5 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.28125359 |
| 6 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.20615399 |
| 7 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 4.20023276 |
| 8 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.19899197 |
| 9 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.18830412 |
| 10 | formation of translation preinitiation complex (GO:0001731) | 4.15758556 |
| 11 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 4.11001629 |
| 12 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 4.11001629 |
| 13 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 4.10912659 |
| 14 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 4.10912659 |
| 15 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 4.10912659 |
| 16 | cullin deneddylation (GO:0010388) | 4.08521048 |
| 17 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.07261108 |
| 18 | negative regulation of ligase activity (GO:0051352) | 4.07261108 |
| 19 | maturation of SSU-rRNA (GO:0030490) | 4.05766892 |
| 20 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.02890448 |
| 21 | protein deneddylation (GO:0000338) | 4.02503739 |
| 22 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.98591047 |
| 23 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.98591047 |
| 24 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.94865583 |
| 25 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.94836018 |
| 26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.92381434 |
| 27 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.91390582 |
| 28 | rRNA modification (GO:0000154) | 3.90733389 |
| 29 | regulation of mitochondrial translation (GO:0070129) | 3.80903520 |
| 30 | viral transcription (GO:0019083) | 3.74175475 |
| 31 | ribosomal small subunit biogenesis (GO:0042274) | 3.73962320 |
| 32 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.73739749 |
| 33 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.72281569 |
| 34 | termination of RNA polymerase III transcription (GO:0006386) | 3.71016031 |
| 35 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.71016031 |
| 36 | 7-methylguanosine mRNA capping (GO:0006370) | 3.70236469 |
| 37 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.69716555 |
| 38 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.68094026 |
| 39 | translational termination (GO:0006415) | 3.64944178 |
| 40 | RNA capping (GO:0036260) | 3.61481860 |
| 41 | 7-methylguanosine RNA capping (GO:0009452) | 3.61481860 |
| 42 | mannosylation (GO:0097502) | 3.58557733 |
| 43 | positive regulation of ligase activity (GO:0051351) | 3.50661966 |
| 44 | telomere maintenance via recombination (GO:0000722) | 3.49720408 |
| 45 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.49220579 |
| 46 | DNA strand elongation (GO:0022616) | 3.48393728 |
| 47 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.46633234 |
| 48 | translational elongation (GO:0006414) | 3.45529638 |
| 49 | ubiquinone biosynthetic process (GO:0006744) | 3.44513809 |
| 50 | translation (GO:0006412) | 3.44191291 |
| 51 | cotranslational protein targeting to membrane (GO:0006613) | 3.41285224 |
| 52 | purine nucleobase biosynthetic process (GO:0009113) | 3.37637310 |
| 53 | metallo-sulfur cluster assembly (GO:0031163) | 3.36219652 |
| 54 | iron-sulfur cluster assembly (GO:0016226) | 3.36219652 |
| 55 | protein targeting to ER (GO:0045047) | 3.36044063 |
| 56 | oxidative phosphorylation (GO:0006119) | 3.35590932 |
| 57 | translational initiation (GO:0006413) | 3.35308620 |
| 58 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.34713518 |
| 59 | neutrophil mediated immunity (GO:0002446) | 3.34555480 |
| 60 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.31767657 |
| 61 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.31679390 |
| 62 | positive regulation of cell cycle arrest (GO:0071158) | 3.31154489 |
| 63 | sequestering of actin monomers (GO:0042989) | 3.30789430 |
| 64 | nucleobase biosynthetic process (GO:0046112) | 3.28858421 |
| 65 | protein localization to endoplasmic reticulum (GO:0070972) | 3.28225817 |
| 66 | ribosome biogenesis (GO:0042254) | 3.24884100 |
| 67 | protein insertion into membrane (GO:0051205) | 3.24773212 |
| 68 | ribosomal large subunit biogenesis (GO:0042273) | 3.24556492 |
| 69 | positive regulation of release of cytochrome c from mitochondria (GO:0090200) | 3.24120604 |
| 70 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.23613451 |
| 71 | amino acid salvage (GO:0043102) | 3.23332007 |
| 72 | L-methionine salvage (GO:0071267) | 3.23332007 |
| 73 | L-methionine biosynthetic process (GO:0071265) | 3.23332007 |
| 74 | pseudouridine synthesis (GO:0001522) | 3.22404485 |
| 75 | GPI anchor biosynthetic process (GO:0006506) | 3.19638256 |
| 76 | maturation of 5.8S rRNA (GO:0000460) | 3.17691683 |
| 77 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.15615373 |
| 78 | rRNA methylation (GO:0031167) | 3.12143645 |
| 79 | spliceosomal snRNP assembly (GO:0000387) | 3.11055511 |
| 80 | rRNA processing (GO:0006364) | 3.10783101 |
| 81 | cellular response to interferon-beta (GO:0035458) | 3.10356037 |
| 82 | cellular protein complex disassembly (GO:0043624) | 3.09712430 |
| 83 | tRNA methylation (GO:0030488) | 3.09635486 |
| 84 | regulation of ligase activity (GO:0051340) | 3.09609701 |
| 85 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.09339989 |
| 86 | ubiquinone metabolic process (GO:0006743) | 3.08693099 |
| 87 | viral mRNA export from host cell nucleus (GO:0046784) | 3.07665864 |
| 88 | regulation of synapse structural plasticity (GO:0051823) | 3.07292146 |
| 89 | chaperone-mediated protein transport (GO:0072321) | 3.07185272 |
| 90 | mitotic recombination (GO:0006312) | 3.06320283 |
| 91 | protein targeting to mitochondrion (GO:0006626) | 3.04983478 |
| 92 | response to peptidoglycan (GO:0032494) | 3.03882324 |
| 93 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.03399788 |
| 94 | cellular component biogenesis (GO:0044085) | 3.01825232 |
| 95 | viral life cycle (GO:0019058) | 3.01820113 |
| 96 | establishment of protein localization to mitochondrion (GO:0072655) | 3.01719099 |
| 97 | peptidyl-histidine modification (GO:0018202) | 3.01274507 |
| 98 | neutrophil activation involved in immune response (GO:0002283) | 3.00575714 |
| 99 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.00356007 |
| 100 | cell cycle G1/S phase transition (GO:0044843) | 3.00356007 |
| 101 | cellular response to nicotine (GO:0071316) | 2.99851898 |
| 102 | positive regulation of mitochondrial fission (GO:0090141) | 2.99725887 |
| 103 | rRNA metabolic process (GO:0016072) | 2.99385678 |
| 104 | establishment of mitochondrion localization (GO:0051654) | 2.97361122 |
| 105 | DNA replication checkpoint (GO:0000076) | 2.95950159 |
| 106 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.95767001 |
| 107 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.95618084 |
| 108 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.95618084 |
| 109 | NADH dehydrogenase complex assembly (GO:0010257) | 2.95618084 |
| 110 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.92958596 |
| 111 | GDP-mannose metabolic process (GO:0019673) | 2.92398456 |
| 112 | C-terminal protein lipidation (GO:0006501) | 2.92312217 |
| 113 | response to interferon-beta (GO:0035456) | 2.92140621 |
| 114 | signal transduction in response to DNA damage (GO:0042770) | 2.91355420 |
| 115 | negative regulation of B cell apoptotic process (GO:0002903) | 2.91283440 |
| 116 | immunoglobulin mediated immune response (GO:0016064) | 2.90840074 |
| 117 | protein complex biogenesis (GO:0070271) | 2.90660467 |
| 118 | regulation of cilium movement (GO:0003352) | 2.89772211 |
| 119 | ATP synthesis coupled proton transport (GO:0015986) | 2.89620493 |
| 120 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.89620493 |
| 121 | negative regulation of G1/S transition of mitotic cell cycle (GO:2000134) | 2.88456987 |
| 122 | negative regulation of cell cycle G1/S phase transition (GO:1902807) | 2.88456987 |
| 123 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.87633659 |
| 124 | platelet dense granule organization (GO:0060155) | 2.87560985 |
| 125 | telomere maintenance via telomere lengthening (GO:0010833) | 2.85702412 |
| 126 | GPI anchor metabolic process (GO:0006505) | 2.85144304 |
| 127 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.82545962 |
| 128 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.82545962 |
| 129 | leukocyte degranulation (GO:0043299) | 2.79786544 |
| 130 | granulocyte activation (GO:0036230) | 2.79666729 |
| 131 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.73583474 |
| 132 | galactose catabolic process (GO:0019388) | 2.73448957 |
| 133 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.71465310 |
| 134 | negative regulation of interleukin-12 production (GO:0032695) | 2.70150847 |
| 135 | positive regulation of TOR signaling (GO:0032008) | 2.62756471 |
| 136 | quinone biosynthetic process (GO:1901663) | 2.62316734 |
| 137 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.61617289 |
| 138 | neutrophil activation (GO:0042119) | 2.61411198 |
| 139 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.59805870 |
| 140 | regulation of chemokine biosynthetic process (GO:0045073) | 2.59225474 |
| 141 | purine nucleotide salvage (GO:0032261) | 2.55464325 |
| 142 | myeloid leukocyte mediated immunity (GO:0002444) | 2.54769118 |
| 143 | regulation of B cell apoptotic process (GO:0002902) | 2.54016011 |
| 144 | phagosome maturation (GO:0090382) | 2.48989700 |
| 145 | C-terminal protein amino acid modification (GO:0018410) | 2.46379266 |
| 146 | negative regulation of glial cell proliferation (GO:0060253) | 2.46141718 |
| 147 | positive regulation of protein homooligomerization (GO:0032464) | 2.45744283 |
| 148 | response to misfolded protein (GO:0051788) | 2.45394053 |
| 149 | myeloid cell activation involved in immune response (GO:0002275) | 2.44734725 |
| 150 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.44005526 |
| 151 | protein maturation by protein folding (GO:0022417) | 2.43667594 |
| 152 | mitochondrion transport along microtubule (GO:0047497) | 2.43632545 |
| 153 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.43632545 |
| 154 | modulation by symbiont of host immune response (GO:0052553) | 2.42567646 |
| 155 | positive regulation by symbiont of host defense response (GO:0052509) | 2.42567646 |
| 156 | modulation by symbiont of host defense response (GO:0052031) | 2.42567646 |
| 157 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.42567646 |
| 158 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.42567646 |
| 159 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.42567646 |
| 160 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.42481060 |
| 161 | viral protein processing (GO:0019082) | 2.41702813 |
| 162 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.40342651 |
| 163 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.39565576 |
| 164 | negative regulation of cell killing (GO:0031342) | 2.39565576 |
| 165 | negative regulation of mast cell activation (GO:0033004) | 2.39532429 |
| 166 | regulation of release of cytochrome c from mitochondria (GO:0090199) | 2.38515651 |
| 167 | respiratory electron transport chain (GO:0022904) | 2.37300938 |
| 168 | type I interferon signaling pathway (GO:0060337) | 2.37299485 |
| 169 | cellular response to type I interferon (GO:0071357) | 2.37299485 |
| 170 | cellular response to arsenic-containing substance (GO:0071243) | 2.36592565 |
| 171 | amino sugar catabolic process (GO:0046348) | 2.36440486 |
| 172 | macrophage activation involved in immune response (GO:0002281) | 2.35735016 |
| 173 | tumor necrosis factor-mediated signaling pathway (GO:0033209) | 2.35080010 |
| 174 | positive regulation of amino acid transport (GO:0051957) | 2.34679014 |
| 175 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.33421107 |
| 176 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.33421107 |
| 177 | electron transport chain (GO:0022900) | 2.33097598 |
| 178 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.32044157 |
| 179 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.32017703 |
| 180 | regulation of protein kinase A signaling (GO:0010738) | 2.31710504 |
| 181 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.31047932 |
| 182 | regulation of autophagic vacuole assembly (GO:2000785) | 2.30262030 |
| 183 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.30163398 |
| 184 | response to type I interferon (GO:0034340) | 2.29751140 |
| 185 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.29489339 |
| 186 | germinal center formation (GO:0002467) | 2.28731603 |
| 187 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.28626135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.03092062 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.58913346 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.07951613 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.00281844 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.81455408 |
| 6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.80834409 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.76925178 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.63566564 |
| 9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.60510569 |
| 10 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.57671659 |
| 11 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.09203206 |
| 12 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.05764152 |
| 13 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.87808976 |
| 14 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.67652583 |
| 15 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.64604193 |
| 16 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.53207303 |
| 17 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.50337891 |
| 18 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.45328248 |
| 19 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.40498485 |
| 20 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.40085017 |
| 21 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.34655240 |
| 22 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.34359702 |
| 23 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.34357924 |
| 24 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.31419174 |
| 25 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.27428282 |
| 26 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.25419264 |
| 27 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.22210583 |
| 28 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.21660625 |
| 29 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.17676741 |
| 30 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.17533471 |
| 31 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 2.15101274 |
| 32 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.14577168 |
| 33 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.11687440 |
| 34 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.09252917 |
| 35 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.04947748 |
| 36 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.98712789 |
| 37 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.93100571 |
| 38 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.92760169 |
| 39 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.90131714 |
| 40 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.88518768 |
| 41 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.87830540 |
| 42 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.87640560 |
| 43 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85901502 |
| 44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.82910290 |
| 45 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.77058470 |
| 46 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.74012086 |
| 47 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.73837612 |
| 48 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.72625939 |
| 49 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.68070599 |
| 50 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67708053 |
| 51 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66748466 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.65691376 |
| 53 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.60015600 |
| 54 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.59671685 |
| 55 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.57949736 |
| 56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57223801 |
| 57 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.56166613 |
| 58 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.54785478 |
| 59 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.54625314 |
| 60 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.54518243 |
| 61 | P68_20966046_ChIP-Seq_HELA_Human | 1.50868340 |
| 62 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.50284664 |
| 63 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.47173022 |
| 64 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.46828046 |
| 65 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.45336996 |
| 66 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.44110028 |
| 67 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.41691948 |
| 68 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.40081212 |
| 69 | UTX_26944678_Chip-Seq_JUKART_Human | 1.39024491 |
| 70 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.38469761 |
| 71 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.37790927 |
| 72 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35683972 |
| 73 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.35182643 |
| 74 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.34874560 |
| 75 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.31920687 |
| 76 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.31376385 |
| 77 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.31222066 |
| 78 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.30866157 |
| 79 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30261343 |
| 80 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.28174736 |
| 81 | MYC_22102868_ChIP-Seq_BL_Human | 1.27312367 |
| 82 | MAF_26560356_Chip-Seq_TH1_Human | 1.25604062 |
| 83 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.24798467 |
| 84 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.24135697 |
| 85 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23720715 |
| 86 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.22995978 |
| 87 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.22671611 |
| 88 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.22407430 |
| 89 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.22126869 |
| 90 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.20477741 |
| 91 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.19336515 |
| 92 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.18363908 |
| 93 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.18163297 |
| 94 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.17752100 |
| 95 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.17019089 |
| 96 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.16497197 |
| 97 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.16388820 |
| 98 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.16061269 |
| 99 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.15405105 |
| 100 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.12565574 |
| 101 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.10932320 |
| 102 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09034338 |
| 103 | P300_27268052_Chip-Seq_Bcells_Human | 1.07564662 |
| 104 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.07421236 |
| 105 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.07387118 |
| 106 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07356346 |
| 107 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07108207 |
| 108 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.06685892 |
| 109 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05331589 |
| 110 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.05227052 |
| 111 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.04434291 |
| 112 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04392569 |
| 113 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.04139029 |
| 114 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.02624087 |
| 115 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02519819 |
| 116 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.02216187 |
| 117 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.01631417 |
| 118 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.01612325 |
| 119 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99730029 |
| 120 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99390088 |
| 121 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.99154583 |
| 122 | SA1_27219007_Chip-Seq_Bcells_Human | 0.98941795 |
| 123 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.98450129 |
| 124 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.97608933 |
| 125 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.97062970 |
| 126 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.96755629 |
| 127 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.96022676 |
| 128 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.94995958 |
| 129 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94757886 |
| 130 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.89883125 |
| 131 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.89369800 |
| 132 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.86894496 |
| 133 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.86369150 |
| 134 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.85869885 |
| 135 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.84401007 |
| 136 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.83819923 |
| 137 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.83570958 |
| 138 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.83092733 |
| 139 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.83061755 |
| 140 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.82461076 |
| 141 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.80827568 |
| 142 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.79826927 |
| 143 | MAF_26560356_Chip-Seq_TH2_Human | 0.79622370 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.56868220 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 3.88333280 |
| 3 | MP0003077_abnormal_cell_cycle | 3.31693707 |
| 4 | MP0003111_abnormal_nucleus_morphology | 3.25531787 |
| 5 | MP0010094_abnormal_chromosome_stability | 3.12347409 |
| 6 | MP0003724_increased_susceptibility_to | 3.09550616 |
| 7 | MP0009840_abnormal_foam_cell | 2.83468234 |
| 8 | MP0008058_abnormal_DNA_repair | 2.74951441 |
| 9 | MP0005671_abnormal_response_to | 2.69351543 |
| 10 | MP0006292_abnormal_olfactory_placode | 2.63972794 |
| 11 | MP0008057_abnormal_DNA_replication | 2.57616688 |
| 12 | MP0001835_abnormal_antigen_presentation | 2.54453075 |
| 13 | MP0002653_abnormal_ependyma_morphology | 2.50869463 |
| 14 | MP0008007_abnormal_cellular_replicative | 2.40697646 |
| 15 | MP0008932_abnormal_embryonic_tissue | 2.27524230 |
| 16 | MP0003763_abnormal_thymus_physiology | 2.25976758 |
| 17 | MP0008877_abnormal_DNA_methylation | 2.22723312 |
| 18 | MP0003123_paternal_imprinting | 2.19883612 |
| 19 | MP0003303_peritoneal_inflammation | 2.17969962 |
| 20 | MP0002396_abnormal_hematopoietic_system | 2.11583626 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.11451714 |
| 22 | MP0008260_abnormal_autophagy | 2.10569767 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 2.05809547 |
| 24 | MP0005360_urolithiasis | 2.02542967 |
| 25 | MP0009764_decreased_sensitivity_to | 2.01671789 |
| 26 | MP0006082_CNS_inflammation | 1.97479104 |
| 27 | MP0003718_maternal_effect | 1.97050639 |
| 28 | MP0002822_catalepsy | 1.95774742 |
| 29 | MP0003786_premature_aging | 1.91593472 |
| 30 | MP0005397_hematopoietic_system_phenotyp | 1.88268847 |
| 31 | MP0001545_abnormal_hematopoietic_system | 1.88268847 |
| 32 | MP0004147_increased_porphyrin_level | 1.84786990 |
| 33 | MP0006036_abnormal_mitochondrial_physio | 1.82938964 |
| 34 | MP0002398_abnormal_bone_marrow | 1.77686009 |
| 35 | MP0005075_abnormal_melanosome_morpholog | 1.76324262 |
| 36 | MP0003186_abnormal_redox_activity | 1.75655740 |
| 37 | MP0009785_altered_susceptibility_to | 1.73660855 |
| 38 | MP0000685_abnormal_immune_system | 1.72354129 |
| 39 | MP0009278_abnormal_bone_marrow | 1.70217206 |
| 40 | MP0006035_abnormal_mitochondrial_morpho | 1.70146891 |
| 41 | MP0004859_abnormal_synaptic_plasticity | 1.68766885 |
| 42 | MP0001986_abnormal_taste_sensitivity | 1.63187670 |
| 43 | MP0000358_abnormal_cell_content/ | 1.60147646 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.58387724 |
| 45 | MP0001800_abnormal_humoral_immune | 1.56949501 |
| 46 | MP0002722_abnormal_immune_system | 1.55101281 |
| 47 | MP0002132_abnormal_respiratory_system | 1.52015544 |
| 48 | MP0001968_abnormal_touch/_nociception | 1.50612626 |
| 49 | MP0005451_abnormal_body_composition | 1.50310474 |
| 50 | MP0002420_abnormal_adaptive_immunity | 1.48919099 |
| 51 | MP0001819_abnormal_immune_cell | 1.47281643 |
| 52 | MP0009697_abnormal_copulation | 1.46609507 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 1.44082815 |
| 54 | MP0004808_abnormal_hematopoietic_stem | 1.43617462 |
| 55 | MP0000716_abnormal_immune_system | 1.43363977 |
| 56 | MP0000703_abnormal_thymus_morphology | 1.42614230 |
| 57 | MP0000604_amyloidosis | 1.40751014 |
| 58 | MP0002429_abnormal_blood_cell | 1.38107924 |
| 59 | MP0002452_abnormal_antigen_presenting | 1.38055537 |
| 60 | MP0002723_abnormal_immune_serum | 1.37020459 |
| 61 | MP0008469_abnormal_protein_level | 1.36521039 |
| 62 | MP0001764_abnormal_homeostasis | 1.36506182 |
| 63 | MP0000313_abnormal_cell_death | 1.35749844 |
| 64 | MP0000490_abnormal_crypts_of | 1.34949799 |
| 65 | MP0004510_myositis | 1.34121514 |
| 66 | MP0010386_abnormal_urinary_bladder | 1.33726248 |
| 67 | MP0002160_abnormal_reproductive_system | 1.32581047 |
| 68 | MP0000343_altered_response_to | 1.31184041 |
| 69 | MP0002019_abnormal_tumor_incidence | 1.30250568 |
| 70 | MP0003329_amyloid_beta_deposits | 1.27514890 |
| 71 | MP0000750_abnormal_muscle_regeneration | 1.27150599 |
| 72 | MP0002735_abnormal_chemical_nociception | 1.26003409 |
| 73 | MP0000015_abnormal_ear_pigmentation | 1.21266014 |
| 74 | MP0009379_abnormal_foot_pigmentation | 1.20096864 |
| 75 | MP0003866_abnormal_defecation | 1.19514595 |
| 76 | MP0000350_abnormal_cell_proliferation | 1.19040235 |
| 77 | MP0006276_abnormal_autonomic_nervous | 1.18763747 |
| 78 | MP0001529_abnormal_vocalization | 1.18506097 |
| 79 | MP0002095_abnormal_skin_pigmentation | 1.17795446 |
| 80 | MP0005025_abnormal_response_to | 1.17750489 |
| 81 | MP0005000_abnormal_immune_tolerance | 1.17632944 |
| 82 | MP0002148_abnormal_hypersensitivity_rea | 1.17359603 |
| 83 | MP0005389_reproductive_system_phenotype | 1.17291439 |
| 84 | MP0001533_abnormal_skeleton_physiology | 1.16359688 |
| 85 | MP0001730_embryonic_growth_arrest | 1.14195135 |
| 86 | MP0000858_altered_metastatic_potential | 1.13863795 |
| 87 | MP0003121_genomic_imprinting | 1.12586735 |
| 88 | MP0000372_irregular_coat_pigmentation | 1.11507873 |
| 89 | MP0003879_abnormal_hair_cell | 1.10104657 |
| 90 | MP0001905_abnormal_dopamine_level | 1.09814707 |
| 91 | MP0001853_heart_inflammation | 1.09461510 |
| 92 | MP0002733_abnormal_thermal_nociception | 1.08875720 |
| 93 | MP0008874_decreased_physiological_sensi | 1.08335271 |
| 94 | MP0004142_abnormal_muscle_tone | 1.07051599 |
| 95 | MP0000465_gastrointestinal_hemorrhage | 1.05563640 |
| 96 | MP0005646_abnormal_pituitary_gland | 1.05259879 |
| 97 | MP0009046_muscle_twitch | 1.03399615 |
| 98 | MP0002405_respiratory_system_inflammati | 1.01538482 |
| 99 | MP0001919_abnormal_reproductive_system | 0.98861515 |
| 100 | MP0005410_abnormal_fertilization | 0.98653318 |
| 101 | MP0001970_abnormal_pain_threshold | 0.97816768 |
| 102 | MP0003075_altered_response_to | 0.97042107 |
| 103 | MP0002210_abnormal_sex_determination | 0.96512372 |
| 104 | MP0002332_abnormal_exercise_endurance | 0.95860965 |
| 105 | MP0000538_abnormal_urinary_bladder | 0.93588221 |
| 106 | MP0009765_abnormal_xenobiotic_induced | 0.93058216 |
| 107 | MP0005310_abnormal_salivary_gland | 0.92497602 |
| 108 | MP0003635_abnormal_synaptic_transmissio | 0.91191683 |
| 109 | MP0002163_abnormal_gland_morphology | 0.91135438 |
| 110 | MP0002063_abnormal_learning/memory/cond | 0.91014367 |
| 111 | MP0000681_abnormal_thyroid_gland | 0.90357642 |
| 112 | MP0003787_abnormal_imprinting | 0.89358812 |
| 113 | MP0004133_heterotaxia | 0.89342342 |
| 114 | MP0002277_abnormal_respiratory_mucosa | 0.89206952 |
| 115 | MP0005387_immune_system_phenotype | 0.89049663 |
| 116 | MP0001790_abnormal_immune_system | 0.89049663 |
| 117 | MP0005464_abnormal_platelet_physiology | 0.88073129 |
| 118 | MP0002572_abnormal_emotion/affect_behav | 0.87714685 |
| 119 | MP0002419_abnormal_innate_immunity | 0.87112197 |
| 120 | MP0001697_abnormal_embryo_size | 0.86346517 |
| 121 | MP0003172_abnormal_lysosome_physiology | 0.86138616 |
| 122 | MP0002080_prenatal_lethality | 0.85226427 |
| 123 | MP0002736_abnormal_nociception_after | 0.84918514 |
| 124 | MP0003806_abnormal_nucleotide_metabolis | 0.84773482 |
| 125 | MP0001929_abnormal_gametogenesis | 0.84565260 |
| 126 | MP0001542_abnormal_bone_strength | 0.83670693 |
| 127 | MP0005084_abnormal_gallbladder_morpholo | 0.83553993 |
| 128 | MP0005384_cellular_phenotype | 0.82714341 |
| 129 | MP0001188_hyperpigmentation | 0.82483577 |
| 130 | MP0003315_abnormal_perineum_morphology | 0.81626085 |
| 131 | MP0005499_abnormal_olfactory_system | 0.81443204 |
| 132 | MP0005394_taste/olfaction_phenotype | 0.81443204 |
| 133 | MP0009763_increased_sensitivity_to | 0.80987195 |
| 134 | MP0005058_abnormal_lysosome_morphology | 0.79978186 |
| 135 | MP0009745_abnormal_behavioral_response | 0.79805901 |
| 136 | MP0008873_increased_physiological_sensi | 0.78828880 |
| 137 | MP0001845_abnormal_inflammatory_respons | 0.78519046 |
| 138 | MP0001119_abnormal_female_reproductive | 0.78270835 |
| 139 | MP0004043_abnormal_pH_regulation | 0.78001683 |
| 140 | MP0003638_abnormal_response/metabolism_ | 0.77564348 |
| 141 | MP0002909_abnormal_adrenal_gland | 0.77516209 |
| 142 | MP0002064_seizures | 0.76857011 |
| 143 | MP0005174_abnormal_tail_pigmentation | 0.75978343 |
| 144 | MP0003183_abnormal_peptide_metabolism | 0.75969047 |
| 145 | MP0008789_abnormal_olfactory_epithelium | 0.75182841 |
| 146 | MP0001145_abnormal_male_reproductive | 0.74178198 |
| 147 | MP0003436_decreased_susceptibility_to | 0.72700052 |
| 148 | MP0000749_muscle_degeneration | 0.72507493 |
| 149 | MP0002006_tumorigenesis | 0.70370019 |
| 150 | MP0008872_abnormal_physiological_respon | 0.69995855 |
| 151 | MP0002166_altered_tumor_susceptibility | 0.68954361 |
| 152 | MP0000653_abnormal_sex_gland | 0.68517435 |
| 153 | MP0001873_stomach_inflammation | 0.65860082 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cerebral hypomyelination (HP:0006808) | 4.27607272 |
| 2 | Hepatocellular necrosis (HP:0001404) | 4.14019664 |
| 3 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 4.00401979 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.88673791 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.88673791 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 3.88673791 |
| 7 | Aplastic anemia (HP:0001915) | 3.85724726 |
| 8 | Abnormal number of erythroid precursors (HP:0012131) | 3.73060394 |
| 9 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.69800604 |
| 10 | Hepatic necrosis (HP:0002605) | 3.69102533 |
| 11 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.66352761 |
| 12 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.66352761 |
| 13 | Acute necrotizing encephalopathy (HP:0006965) | 3.60594127 |
| 14 | Mitochondrial inheritance (HP:0001427) | 3.53103717 |
| 15 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.38283415 |
| 16 | Increased CSF lactate (HP:0002490) | 3.33489051 |
| 17 | Vacuolated lymphocytes (HP:0001922) | 3.30938272 |
| 18 | Microretrognathia (HP:0000308) | 3.28435886 |
| 19 | Birth length less than 3rd percentile (HP:0003561) | 3.26297960 |
| 20 | Reticulocytopenia (HP:0001896) | 3.21538156 |
| 21 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.17478132 |
| 22 | IgM deficiency (HP:0002850) | 3.05470688 |
| 23 | Type 2 muscle fiber atrophy (HP:0003554) | 3.00116290 |
| 24 | Type I transferrin isoform profile (HP:0003642) | 2.91995676 |
| 25 | Muscle fiber atrophy (HP:0100295) | 2.89730703 |
| 26 | Increased serum lactate (HP:0002151) | 2.87331598 |
| 27 | Progressive macrocephaly (HP:0004481) | 2.86804590 |
| 28 | Increased muscle lipid content (HP:0009058) | 2.86376819 |
| 29 | Stomatitis (HP:0010280) | 2.84331736 |
| 30 | Renal Fanconi syndrome (HP:0001994) | 2.82080163 |
| 31 | Increased intramyocellular lipid droplets (HP:0012240) | 2.76155140 |
| 32 | Abnormality of the anterior horn cell (HP:0006802) | 2.74970947 |
| 33 | Degeneration of anterior horn cells (HP:0002398) | 2.74970947 |
| 34 | Mutism (HP:0002300) | 2.74522529 |
| 35 | Acute encephalopathy (HP:0006846) | 2.74079239 |
| 36 | Petechiae (HP:0000967) | 2.73721163 |
| 37 | Generalized aminoaciduria (HP:0002909) | 2.70287164 |
| 38 | Polyphagia (HP:0002591) | 2.68491851 |
| 39 | Cholecystitis (HP:0001082) | 2.67877232 |
| 40 | Abnormal gallbladder physiology (HP:0012438) | 2.67877232 |
| 41 | Oral leukoplakia (HP:0002745) | 2.67812254 |
| 42 | Abnormality of macrophages (HP:0004311) | 2.64510393 |
| 43 | Severe visual impairment (HP:0001141) | 2.63384429 |
| 44 | CNS hypomyelination (HP:0003429) | 2.61760337 |
| 45 | Dysostosis multiplex (HP:0000943) | 2.59633421 |
| 46 | Mediastinal lymphadenopathy (HP:0100721) | 2.57516662 |
| 47 | Orchitis (HP:0100796) | 2.56013079 |
| 48 | Rough bone trabeculation (HP:0100670) | 2.55144161 |
| 49 | Loss of speech (HP:0002371) | 2.54312478 |
| 50 | Tongue fasciculations (HP:0001308) | 2.54026822 |
| 51 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.52362019 |
| 52 | Microvesicular hepatic steatosis (HP:0001414) | 2.51714345 |
| 53 | 3-Methylglutaconic aciduria (HP:0003535) | 2.50890775 |
| 54 | Poor head control (HP:0002421) | 2.49061286 |
| 55 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.48334431 |
| 56 | Lactic acidosis (HP:0003128) | 2.47588469 |
| 57 | Large eyes (HP:0001090) | 2.47290170 |
| 58 | IgG deficiency (HP:0004315) | 2.46668907 |
| 59 | Retrobulbar optic neuritis (HP:0100654) | 2.46497133 |
| 60 | Optic neuritis (HP:0100653) | 2.46497133 |
| 61 | Breast hypoplasia (HP:0003187) | 2.43839984 |
| 62 | Carpal bone hypoplasia (HP:0001498) | 2.43146773 |
| 63 | Premature graying of hair (HP:0002216) | 2.42176358 |
| 64 | Patent foramen ovale (HP:0001655) | 2.41471926 |
| 65 | Macrocytic anemia (HP:0001972) | 2.41243410 |
| 66 | Premature ovarian failure (HP:0008209) | 2.41051930 |
| 67 | Myositis (HP:0100614) | 2.40900346 |
| 68 | Thrombocytosis (HP:0001894) | 2.40558395 |
| 69 | Progressive microcephaly (HP:0000253) | 2.36808216 |
| 70 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.35456652 |
| 71 | Patellar aplasia (HP:0006443) | 2.33660679 |
| 72 | Hypothermia (HP:0002045) | 2.33052630 |
| 73 | Disinhibition (HP:0000734) | 2.32664562 |
| 74 | Respiratory failure (HP:0002878) | 2.32640267 |
| 75 | Lipid accumulation in hepatocytes (HP:0006561) | 2.32055724 |
| 76 | Pancytopenia (HP:0001876) | 2.29530911 |
| 77 | Obstructive lung disease (HP:0006536) | 2.28189488 |
| 78 | Chronic obstructive pulmonary disease (HP:0006510) | 2.28189488 |
| 79 | Emotional lability (HP:0000712) | 2.27935972 |
| 80 | Unsteady gait (HP:0002317) | 2.27027926 |
| 81 | Pallor (HP:0000980) | 2.25948794 |
| 82 | Bone marrow hypocellularity (HP:0005528) | 2.25187384 |
| 83 | Secondary amenorrhea (HP:0000869) | 2.24368224 |
| 84 | Episodic fever (HP:0001954) | 2.23932954 |
| 85 | Myelodysplasia (HP:0002863) | 2.23517759 |
| 86 | Reduced antithrombin III activity (HP:0001976) | 2.23394743 |
| 87 | Cellular immunodeficiency (HP:0005374) | 2.22169704 |
| 88 | Abnormality of the ileum (HP:0001549) | 2.20661372 |
| 89 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.19597194 |
| 90 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.18611768 |
| 91 | Abnormality of glycolysis (HP:0004366) | 2.18504892 |
| 92 | Increased serum pyruvate (HP:0003542) | 2.18504892 |
| 93 | Abnormality of the preputium (HP:0100587) | 2.17593653 |
| 94 | Absent thumb (HP:0009777) | 2.15531920 |
| 95 | Abnormality of eosinophils (HP:0001879) | 2.15438480 |
| 96 | Exertional dyspnea (HP:0002875) | 2.15239540 |
| 97 | Severe muscular hypotonia (HP:0006829) | 2.13867552 |
| 98 | Agnosia (HP:0010524) | 2.12350269 |
| 99 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.11392998 |
| 100 | Dicarboxylic aciduria (HP:0003215) | 2.11392998 |
| 101 | B lymphocytopenia (HP:0010976) | 2.11136533 |
| 102 | Abnormality of B cell number (HP:0010975) | 2.11136533 |
| 103 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.10730095 |
| 104 | Eosinophilia (HP:0001880) | 2.10562445 |
| 105 | Recurrent abscess formation (HP:0002722) | 2.09721615 |
| 106 | Muscle fibrillation (HP:0010546) | 2.09534683 |
| 107 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.09185239 |
| 108 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.09185239 |
| 109 | Abnormal protein glycosylation (HP:0012346) | 2.09185239 |
| 110 | Abnormal glycosylation (HP:0012345) | 2.09185239 |
| 111 | Exercise intolerance (HP:0003546) | 2.08455531 |
| 112 | Meckel diverticulum (HP:0002245) | 2.07614326 |
| 113 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.07097301 |
| 114 | Pulmonary fibrosis (HP:0002206) | 2.06590087 |
| 115 | CNS demyelination (HP:0007305) | 2.06519768 |
| 116 | Purpura (HP:0000979) | 2.06332180 |
| 117 | Neuronal loss in central nervous system (HP:0002529) | 2.05910655 |
| 118 | Colon cancer (HP:0003003) | 2.03723916 |
| 119 | Prolonged neonatal jaundice (HP:0006579) | 2.03139267 |
| 120 | Abnormality of dental color (HP:0011073) | 2.00571865 |
| 121 | Failure to thrive in infancy (HP:0001531) | 1.98207919 |
| 122 | Increased hepatocellular lipid droplets (HP:0006565) | 1.98130438 |
| 123 | Myokymia (HP:0002411) | 1.96742344 |
| 124 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 1.96510221 |
| 125 | Diminished motivation (HP:0000745) | 1.92446900 |
| 126 | Abnormal hair whorl (HP:0010721) | 1.90495340 |
| 127 | Lymphoma (HP:0002665) | 1.89528375 |
| 128 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.88518327 |
| 129 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.88150884 |
| 130 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.88150884 |
| 131 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.88150884 |
| 132 | Type II lissencephaly (HP:0007260) | 1.87875183 |
| 133 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.87655134 |
| 134 | Cholelithiasis (HP:0001081) | 1.87201975 |
| 135 | Cerebral edema (HP:0002181) | 1.87012756 |
| 136 | Cortical visual impairment (HP:0100704) | 1.86391836 |
| 137 | Optic disc pallor (HP:0000543) | 1.86169078 |
| 138 | Amaurosis fugax (HP:0100576) | 1.85638473 |
| 139 | Combined immunodeficiency (HP:0005387) | 1.85594815 |
| 140 | Poor suck (HP:0002033) | 1.85154798 |
| 141 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.84597241 |
| 142 | Gait imbalance (HP:0002141) | 1.84001385 |
| 143 | Recurrent bacterial skin infections (HP:0005406) | 1.83677480 |
| 144 | Severe combined immunodeficiency (HP:0004430) | 1.83625218 |
| 145 | Granulocytopenia (HP:0001913) | 1.82543874 |
| 146 | Neutropenia (HP:0001875) | 1.82521846 |
| 147 | Broad distal phalanx of finger (HP:0009836) | 1.82325615 |
| 148 | Panhypogammaglobulinemia (HP:0003139) | 1.81640447 |
| 149 | Cleft eyelid (HP:0000625) | 1.79945807 |
| 150 | Upper limb muscle weakness (HP:0003484) | 1.79100816 |
| 151 | Retinal dysplasia (HP:0007973) | 1.77489520 |
| 152 | Agitation (HP:0000713) | 1.76761043 |
| 153 | Personality changes (HP:0000751) | 1.76526857 |
| 154 | Abnormality of T cell physiology (HP:0011840) | 1.75121864 |
| 155 | Hepatosplenomegaly (HP:0001433) | 1.75056270 |
| 156 | Encephalitis (HP:0002383) | 1.73470139 |
| 157 | Poikiloderma (HP:0001029) | 1.73231353 |
| 158 | Recurrent bronchitis (HP:0002837) | 1.73104929 |
| 159 | Congenital primary aphakia (HP:0007707) | 1.73023690 |
| 160 | Delusions (HP:0000746) | 1.72835487 |
| 161 | Nephrogenic diabetes insipidus (HP:0009806) | 1.71974839 |
| 162 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.71947310 |
| 163 | Abnormality of T cells (HP:0002843) | 1.70543152 |
| 164 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.70293932 |
| 165 | Abnormal trabecular bone morphology (HP:0100671) | 1.70156429 |
| 166 | Limb dystonia (HP:0002451) | 1.69152246 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 5.82315841 |
| 2 | BUB1 | 5.37181056 |
| 3 | STK16 | 3.74543088 |
| 4 | MAP4K2 | 3.62983689 |
| 5 | ACVR1B | 3.11361142 |
| 6 | TESK2 | 2.83464617 |
| 7 | WEE1 | 2.81180115 |
| 8 | MAP3K12 | 2.68721760 |
| 9 | TSSK6 | 2.54981609 |
| 10 | EIF2AK1 | 2.45784313 |
| 11 | NME2 | 2.36762540 |
| 12 | PIM2 | 2.35998420 |
| 13 | TNK2 | 2.30310558 |
| 14 | MATK | 1.98531624 |
| 15 | MARK1 | 1.97787946 |
| 16 | MAP4K1 | 1.96064804 |
| 17 | PLK4 | 1.80975097 |
| 18 | BRSK2 | 1.74910707 |
| 19 | BRAF | 1.73379909 |
| 20 | NEK1 | 1.72695100 |
| 21 | VRK1 | 1.70625841 |
| 22 | IRAK3 | 1.68862795 |
| 23 | ARAF | 1.65162896 |
| 24 | CDK8 | 1.64551724 |
| 25 | SIK3 | 1.57232388 |
| 26 | EIF2AK3 | 1.57045021 |
| 27 | SRPK1 | 1.56068684 |
| 28 | MAPKAPK3 | 1.55750037 |
| 29 | SIK2 | 1.54263814 |
| 30 | CCNB1 | 1.53392574 |
| 31 | DAPK1 | 1.41379314 |
| 32 | NME1 | 1.40748158 |
| 33 | BRSK1 | 1.38064258 |
| 34 | TXK | 1.37553461 |
| 35 | DYRK1B | 1.37478221 |
| 36 | IRAK4 | 1.35083666 |
| 37 | MAP2K4 | 1.30563682 |
| 38 | TAOK1 | 1.29557376 |
| 39 | CDC7 | 1.27210781 |
| 40 | VRK2 | 1.26984304 |
| 41 | CDK19 | 1.26662625 |
| 42 | TESK1 | 1.25619543 |
| 43 | ZAK | 1.24181884 |
| 44 | PLK1 | 1.22781625 |
| 45 | BCKDK | 1.22249538 |
| 46 | ERN1 | 1.20170606 |
| 47 | BMPR1B | 1.19838584 |
| 48 | KDR | 1.15465592 |
| 49 | NEK2 | 1.15269053 |
| 50 | ZAP70 | 1.12279023 |
| 51 | MARK3 | 1.10634082 |
| 52 | RPS6KB2 | 1.07942269 |
| 53 | RIPK4 | 1.07599353 |
| 54 | CSNK1G3 | 1.05294488 |
| 55 | MYLK | 1.04514844 |
| 56 | TLK1 | 1.02996144 |
| 57 | AURKA | 0.97765040 |
| 58 | CDK7 | 0.97285788 |
| 59 | FGR | 0.96594717 |
| 60 | TGFBR1 | 0.95856088 |
| 61 | MAP3K5 | 0.91906303 |
| 62 | AURKB | 0.90530959 |
| 63 | TTK | 0.88438447 |
| 64 | PLK3 | 0.88173880 |
| 65 | RPS6KA4 | 0.88098783 |
| 66 | FES | 0.88037513 |
| 67 | KIT | 0.87835880 |
| 68 | TEC | 0.85798646 |
| 69 | CSF1R | 0.85450904 |
| 70 | ATR | 0.85322625 |
| 71 | CSNK1A1L | 0.83076043 |
| 72 | SYK | 0.82860992 |
| 73 | TAOK2 | 0.80314150 |
| 74 | GRK6 | 0.79742530 |
| 75 | MAP3K11 | 0.78800286 |
| 76 | PDK2 | 0.78266645 |
| 77 | BTK | 0.78193470 |
| 78 | AKT3 | 0.77967976 |
| 79 | PKN1 | 0.76450151 |
| 80 | MAP3K4 | 0.73715511 |
| 81 | EEF2K | 0.73650785 |
| 82 | DAPK2 | 0.73385780 |
| 83 | DYRK2 | 0.73211219 |
| 84 | MAP3K3 | 0.73124006 |
| 85 | JAK3 | 0.71433683 |
| 86 | CSNK1G2 | 0.71172669 |
| 87 | BLK | 0.70007235 |
| 88 | MAPK13 | 0.69638586 |
| 89 | PAK4 | 0.67601270 |
| 90 | STK10 | 0.67220426 |
| 91 | PRKD2 | 0.67200611 |
| 92 | MUSK | 0.65935714 |
| 93 | EPHB1 | 0.65557697 |
| 94 | CSNK2A1 | 0.61905672 |
| 95 | MAP3K1 | 0.60800935 |
| 96 | CHEK2 | 0.60271517 |
| 97 | ABL2 | 0.60124067 |
| 98 | GRK5 | 0.59819112 |
| 99 | IKBKB | 0.59100585 |
| 100 | MAP2K7 | 0.59046234 |
| 101 | TBK1 | 0.58683828 |
| 102 | DAPK3 | 0.58030240 |
| 103 | RPS6KA5 | 0.58021052 |
| 104 | MKNK1 | 0.57544944 |
| 105 | MST4 | 0.57303790 |
| 106 | PIM1 | 0.56460347 |
| 107 | PAK1 | 0.54571251 |
| 108 | MAPKAPK5 | 0.54398721 |
| 109 | TYK2 | 0.53157453 |
| 110 | CAMKK2 | 0.51263238 |
| 111 | CASK | 0.49396118 |
| 112 | ILK | 0.49046208 |
| 113 | CSNK2A2 | 0.48951011 |
| 114 | PASK | 0.48572108 |
| 115 | PRKCI | 0.47934360 |
| 116 | MAP3K8 | 0.46985623 |
| 117 | ADRBK2 | 0.46848050 |
| 118 | CSNK1G1 | 0.46384347 |
| 119 | IKBKE | 0.45241283 |
| 120 | GRK7 | 0.43905437 |
| 121 | FLT3 | 0.43772439 |
| 122 | RPS6KA2 | 0.43527504 |
| 123 | LYN | 0.42818168 |
| 124 | LIMK1 | 0.41527755 |
| 125 | CSK | 0.41348870 |
| 126 | LCK | 0.40317700 |
| 127 | RPS6KA6 | 0.39868284 |
| 128 | CDK14 | 0.39855632 |
| 129 | STK24 | 0.39585490 |
| 130 | MAP2K3 | 0.39481449 |
| 131 | MAP2K6 | 0.39144437 |
| 132 | EPHA3 | 0.38589210 |
| 133 | WNK3 | 0.38405983 |
| 134 | BMPR2 | 0.37028182 |
| 135 | DYRK3 | 0.36443935 |
| 136 | NTRK2 | 0.36384746 |
| 137 | RPS6KC1 | 0.36206843 |
| 138 | RPS6KL1 | 0.36206843 |
| 139 | IRAK2 | 0.36006122 |
| 140 | CDK11A | 0.35828187 |
| 141 | MKNK2 | 0.32676456 |
| 142 | DDR2 | 0.32243913 |
| 143 | PRKCQ | 0.32165893 |
| 144 | EIF2AK2 | 0.31782782 |
| 145 | MAPKAPK2 | 0.31474426 |
| 146 | PRKCZ | 0.31439707 |
| 147 | LRRK2 | 0.31398011 |
| 148 | CDK5 | 0.28548900 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.20820338 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.35212012 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 3.81063240 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.55869980 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 3.13796609 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 2.88975490 |
| 7 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.85887298 |
| 8 | Spliceosome_Homo sapiens_hsa03040 | 2.58557737 |
| 9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.53213710 |
| 10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.40220165 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.38428413 |
| 12 | RNA transport_Homo sapiens_hsa03013 | 2.30567828 |
| 13 | Homologous recombination_Homo sapiens_hsa03440 | 2.28961553 |
| 14 | Parkinsons disease_Homo sapiens_hsa05012 | 2.23400274 |
| 15 | Protein export_Homo sapiens_hsa03060 | 2.13616574 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.92386450 |
| 17 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.88205641 |
| 18 | Basal transcription factors_Homo sapiens_hsa03022 | 1.82731383 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.80184769 |
| 20 | Huntingtons disease_Homo sapiens_hsa05016 | 1.72552927 |
| 21 | Lysosome_Homo sapiens_hsa04142 | 1.71473924 |
| 22 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.70007938 |
| 23 | RNA degradation_Homo sapiens_hsa03018 | 1.67325097 |
| 24 | Cell cycle_Homo sapiens_hsa04110 | 1.64779491 |
| 25 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.62308632 |
| 26 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.60947492 |
| 27 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.60002964 |
| 28 | Nicotine addiction_Homo sapiens_hsa05033 | 1.57988167 |
| 29 | Tuberculosis_Homo sapiens_hsa05152 | 1.57190664 |
| 30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.49687543 |
| 31 | Purine metabolism_Homo sapiens_hsa00230 | 1.46738834 |
| 32 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.40708642 |
| 33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.39958081 |
| 34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.38723767 |
| 35 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.36766225 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.36050382 |
| 37 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.35263668 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.34368447 |
| 39 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.29184239 |
| 40 | Malaria_Homo sapiens_hsa05144 | 1.27907063 |
| 41 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.26045594 |
| 42 | Alzheimers disease_Homo sapiens_hsa05010 | 1.21341803 |
| 43 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20771114 |
| 44 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.19990777 |
| 45 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.18390430 |
| 46 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.18003934 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.11808337 |
| 48 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.10161708 |
| 49 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.09970775 |
| 50 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.01687765 |
| 51 | Pertussis_Homo sapiens_hsa05133 | 1.01600168 |
| 52 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.00717950 |
| 53 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.00520223 |
| 54 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.96424536 |
| 55 | GABAergic synapse_Homo sapiens_hsa04727 | 0.86494864 |
| 56 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.82033931 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.81420001 |
| 58 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.79867401 |
| 59 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.79464321 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.79239303 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78600630 |
| 62 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.78387830 |
| 63 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.78216519 |
| 64 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.76912087 |
| 65 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.75248607 |
| 66 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.75068851 |
| 67 | Allograft rejection_Homo sapiens_hsa05330 | 0.74123062 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.73239443 |
| 69 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.72513577 |
| 70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.72251581 |
| 71 | Peroxisome_Homo sapiens_hsa04146 | 0.72014607 |
| 72 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.71899321 |
| 73 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.70705883 |
| 74 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.65738699 |
| 75 | Phototransduction_Homo sapiens_hsa04744 | 0.63920333 |
| 76 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.61698313 |
| 77 | Legionellosis_Homo sapiens_hsa05134 | 0.61536088 |
| 78 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.61014072 |
| 79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58108784 |
| 80 | Morphine addiction_Homo sapiens_hsa05032 | 0.57982686 |
| 81 | Measles_Homo sapiens_hsa05162 | 0.57773511 |
| 82 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.57615944 |
| 83 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.57590036 |
| 84 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56803712 |
| 85 | Viral myocarditis_Homo sapiens_hsa05416 | 0.56113846 |
| 86 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.55931488 |
| 87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.55681489 |
| 88 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.55076670 |
| 89 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.51927021 |
| 90 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.51266705 |
| 91 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50286524 |
| 92 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.49420218 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.48796671 |
| 94 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.48127008 |
| 95 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.47699667 |
| 96 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.46837143 |
| 97 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.46426066 |
| 98 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.45757420 |
| 99 | Shigellosis_Homo sapiens_hsa05131 | 0.45391054 |
| 100 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45058020 |
| 101 | Carbon metabolism_Homo sapiens_hsa01200 | 0.44584530 |
| 102 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.43549549 |
| 103 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.43235823 |
| 104 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.42721818 |
| 105 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.42401475 |
| 106 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41866511 |
| 107 | Hepatitis C_Homo sapiens_hsa05160 | 0.41485577 |
| 108 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.39488246 |
| 109 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38471075 |
| 110 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.37752422 |
| 111 | Sulfur relay system_Homo sapiens_hsa04122 | 0.36657085 |
| 112 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.36243355 |
| 113 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.36024910 |
| 114 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.35696987 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35506791 |
| 116 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35255057 |
| 117 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.33958513 |
| 118 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.33746477 |
| 119 | Apoptosis_Homo sapiens_hsa04210 | 0.33498483 |
| 120 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33107492 |
| 121 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32503028 |
| 122 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.32173957 |
| 123 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31867693 |
| 124 | Influenza A_Homo sapiens_hsa05164 | 0.31749708 |
| 125 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.30939865 |
| 126 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.29680915 |
| 127 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.28406797 |
| 128 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.27876227 |
| 129 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.23292969 |
| 130 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.22320889 |
| 131 | Phagosome_Homo sapiens_hsa04145 | 0.19819316 |
| 132 | Leishmaniasis_Homo sapiens_hsa05140 | 0.18717616 |
| 133 | Hepatitis B_Homo sapiens_hsa05161 | 0.17062263 |
| 134 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.16181415 |
| 135 | Asthma_Homo sapiens_hsa05310 | 0.15437105 |
| 136 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.14083185 |
| 137 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.13852127 |
| 138 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.12131594 |
| 139 | Alcoholism_Homo sapiens_hsa05034 | 0.12044743 |
| 140 | Colorectal cancer_Homo sapiens_hsa05210 | 0.10854762 |

